Robert W. Baird analyst Thomas Russo commented on Vertex Pharmaceuticals Inc. (Nasdaq: VRTX) following this morning's weakness (-11%) due to ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE